1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: BMT 0499 Solid, NCT00179816
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 1 to 30 Sponsor: Other Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 20 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: 100220, IND 59,056, NCT01222780
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 12 to 65 Sponsor: Other Protocol IDs: 2008-0378, NCT00936936
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 21 Sponsor: NCI, Other Protocol IDs: ADVL0921, NCI-2011-02051, CDR0000680512, U10CA098543, COG-ADVL0921, NCT01154816
|
|
6.
|
Phase: Phase I Type: Treatment Status: Active Age: 2 to 21 Sponsor: Other Protocol IDs: RADIANT, NCT01625351
|